Vjhemonc Podcast

The treatment landscape of acute myeloid and lymphoblastic leukemia continues to evolve with the addition of novel therapies and methods... The post iwAL 2019: looking to the future of acute leukemia therapy appeared first on VJHemOnc.

This is an exciting time in the acute leukemia field, with advances in both the treatment landscape and the pathology... The post Acute leukemia: pushing boundaries in disease management appeared first on VJHemOnc.

Precision medicine provides an array of benefits for the treatment of non-Hodgkin lymphoma patients, but it also has its challenges.... The post CAR T-cell therapy and precision medicine in non-Hodgkin lymphoma appeared first on VJHemOnc.

Determining measurable residual disease (MRD) status is undoubtedly proving to be an effective method of prognostication and measurement of response... The post MRD testing in multiple myeloma: new technology with promising clinical applications appeared first on VJHemOnc.

CAR T-cell therapy presents the opportunity to completely revolutionize the treatment of multiple myeloma, with research currently exploring the optimal... The post CAR T-cells in myeloma: exploratory targets, payment models & treatment sequence appeared first on VJHemOnc.

CAR T-cells have demonstrated impressive efficacy in a variety of hematological malignancies, but their use in chronic lymphocytic leukemia (CLL)... The post Patient discussion at EHA 2018: CAR T-cells and MRD in CLL appeared first on VJHemOnc.

Chronic lymphocytic leukemia (CLL) is experiencing a revolution in its treatment approaches. New therapies are constantly in development, and the... The post CLL therapies today: novel agents, combinations & the future of the field appeared first on VJHemOnc.

Over the last several years, CAR T-cell therapy has emerged as a revolution in immunotherapy, with incredible results to date.... The post CAR T-cell therapy: where are we now and what’s in store for the future? appeared first on VJHemOnc.

Measurable residual disease (MRD) has been a hot topic of interest due to its potential applications in the clinical setting.... The post Focus on MRD: current landscape and future questions in hemonc appeared first on VJHemOnc.

A stimulating session on the implications of genomic data for the management of acute myeloid leukemia (AML) and acute lymphoblastic... The post Acute leukemias discussion: what does genomics and epigenomics tell us about patient management? appeared first on VJHemOnc.

The use of minimal residual disease (MRD) in the management of acute leukemias is a hotly debated topic. Despite the... The post Acute leukemias: is MRD already a surrogate for survival? appeared first on VJHemOnc.

Immunotherapy has emerged in recent years as an effective novel treatment for lymphoma, with studies constantly striving to identify new... The post Revolutionary immunotherapies for lymphoma appeared first on VJHemOnc.

In this lively discussion, Catherine Bollard, MBChB, MD, FRACP, FRCPA, from the Children’s National Health System and George Washington University,... The post Latest advances and current challenges in immunotherapies for lymphoma appeared first on VJHemOnc.

In this exciting feature, Carlo Croce, MD, from Ohio State University, Columbus, OH, provides an overview of the history of... The post The circle of CLL: from gene discovery to targeted treatment appeared first on VJHemOnc.

This is a very exciting time for multiple myeloma (MM) research, with advances in a range of areas from new... The post Myeloma 2017 day 2 highlights: MRD, targeted therapies and imaging advances appeared first on VJHemOnc.

Fantastic advances in immunotherapy, including CAR T-cells, bispecific antibodies and potential immunotherapy combinations, were presented at the Myeloma 2017 meeting... The post Myeloma 2017 day 1 highlights: immunotherapy advances, a new MM subtype and liquid biopsies appeared first on VJHemOnc.

The highly anticipated panel discussion on the hot topic of MRD at the Myeloma 2017 meeting in Edinburgh, UK produced... The post Debate on the use of MRD for multiple myeloma management appeared first on VJHemOnc.